Table 2. Relationship between the 5hmC level and clinicopathological features of patients with gliomas.
| Clinicopathological features | Total cases (n = 287) |
||
|---|---|---|---|
| 5hmC (0–3) | 5hmC (4–9) | Pvalue | |
| Gender | |||
| Male: Female | 93:62 | 73:59 | 0.422 |
| Age | |||
| ≤40:>40 | 61:94 | 82:50 | 0.000 |
| WHO grade | |||
| I∼II: III∼IV | 54:101 | 100:32 | 0.000 |
| Vital status | |||
| Alive:death | 59:96 | 85:47 | 0.000 |
| KPS | |||
| ≥80:<80 | 87:68 | 92:40 | 0.018 |
| *Tumor size (cm) | |||
| <50 cm3: ≥ 50cm3 | 60:95 | 70:62 | 0.015 |
| Extent of resection | |||
| Total:Subtotal | 119:36 | 93:39 | 0.225 |
| Adjuvant treatment | |||
| Yes:No | 113:42 | 99:33 | 0.544 |
*Available data were 260 cases.